made, the more it will be influenced by organic binding. This means that a fall in the 20-minute uptake during treatment with carbimazole is due partly to impairment of organic binding, and this effect must be taken into account if conclusions on thyroid suppression are based on this measurement. Of interest in this context are some recent observations by Shimmins et al. (1971) , who found that the 20-minute uptake of 132I fell by about 20% as soon as treatment with carbimazole was started.
Attempts to predict the outcome of antithyroid drug treatment on the basis of thyroid suppressibility have met with limited success (Alexander et al., 1970; Goolden et al., 1971; Lowry et al., 1971) . Suppression is not necessarily indicative of long-term remission, and patients who fail to suppress do not always relapse when treatment is discontinued. Despite these limitations the examination of thyroid function during treatmnent may sometimes be helpful, and for this purpose 99Tcm uptake would seem to be the most appropriate method.
In our experience 99Tcm uptake measurements have proved very satisfactory for the routine assessment of thyroid function. In the absence of a direct comparison it cannot be said that they are any more efficient than early radioiodine uptake tests in differentiating between euthyroid and hyperthyroid individuals, but we think it unlikely that such a comparison would show any great difference. Points in favour of 9eTcm are that it gives a small radiation dose to the thyroid and that tests can be repeated at short time intervals. Furthermore, techniques for measuring the uptake of this radioisotope allow accurate correction for extrathyroidal activity, an essential requirement for any early thyroid uptake measurement. The reproducibility of the method described is such that suppression tests can be used when necessary even when thyroid uptake is within the normal range. Finally, 'JTcm is particularly well suited for the assessment of thyroid function in patients being treated with an antithyroid drug. Medical3Journal, 1971, 4, 399-400 Summary The efficacy of pyrantel embonate (1,4,5,6-tetrahydro-1-methyl-2-(trans-2-(2-thienyl)-vinyl)-pyrimidine embonic acid salt; Combantrin) was evaluated in 60 cases of hookworm infestation. They were divided into six groups of 10 cases. Pyrantel embonate was administered orally, in dosage schedules (randomized) of 100, 75, 50, 20, 15, and 10 mg/kg of body weight. The stool examination for hookworm ova and coproculture were positive in each case. The predominant species was Ancylostoma duodenale (in 58 patients). After treatment with pyrantel embonate the stool examination for hookworm ova and coproculture were negative on the 10th and 15th days in each group. The blood levels of the drug were significantly higher in patients receiving 100 Routine haematological studies and liver function testsnamely, serum bilirubin, alkaline phosphatase, serum aspartate aminotransferase, serum alanine aminotransferase, and blood urea estimation-were undertaken before treatment and on the third and tenth days after treatment, standard methods being used (Varley, 1967) .
Twenty-four-hour sample of stool was examined for faecal egg load by the Stoll and Hausheer (1926) technique on three consecutive days before therapy and on the 10th, 11th, 12th, 18th, 19th, and 20th days after administration of the drug. No patients with an ova count below 3,000/g of faeces was included in this trial. The 24-hour sample of stool was sieved for identification of adult worms on the 1st, 2nd, and 3rd days of treatment.
Coproculture was performed according to the method of Belding (1965) 
Observations and Comments
The results of therapy are summarized in Table I . The coproculture was positive in all cases before treatment, and identification of species showed Ancylostoma duodenale in 57 patients and Necator americanus i two. Species identification after deworming by examinaton of adult worms in stool gave similar results, and there was a direct correlation between hookworm ova count and worms expelled. The stool was free from ova on the 10th, 12th, 15th, 18th, 19th, and 20th days. The coproculture was negative on the 10th, 15th, and 20th days in all six groups (Table I) . Hookworm ova were not found by the concentraton method between the 10th and 20th posttreatment days. Hence complete eradicaton (100%) of hookworm ova was achieved in each group.
There was no evidence of hepatocellular or renal toxicity as indicated by serum bilirubin, alkaine phosphatase, tsim levels, and blood urea on the 3rd and 10th post-treatment days in any group. The differences in blood drug levels at 4 and 12 hours after administration of the drug were not significant in groups C, D, E, and F (Table II) . In groups A and B the 12-hour blood level was significantly higher than at four hours (Table II) . This shows a higher rate of absorption of the drug at 100-and 75-mg/kg dosage. Though these dosage schedules seemed very effective, side effects like nausea and vomiting were noted in one patient each in groups A and B. Otherwise the drug was well tolerated. In this trial the drug was found to be effective in the eradicadon of hookworm infection even at the lowest dosage schedule of 10 mg/kg. It is necessary to extend further tias of the drug at still lower dosage to find out the minimum effective dose against hookworm.
